Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from Operating Activities
Net Loss	$ (13,203,852)	$ (16,575,317)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities
Stock based compensation	718,549	720,402
Credit losses	439,161	94,714
Gain on settlement of assumed liabilities
Change in fair market value of warrant liability	(2,738)	(58,276)
Loss on change in fair market value of contingent consideration (Note 2)		240,000
Gain on settlement of debt	(796,450)
Gain on settlement of accounts payable	(268,376)
Gain on settlement of contingent consideration	(7,045,936)	(1,700,000)
Loss on impairment of goodwill and intangible assets	6,473,310	6,993,075
Change in reserve for Obsolescence in Inventory	451,197	(52,208)
Amortization of right-of-use asset	1,066,298	1,213,949
Depreciation and amortization	2,974,944	1,991,798
Amortization of debt discount	896,297	223,643
Changes in operating assets and liabilities, net of effects of acquisitions:
Accounts receivable	(1,090,064)	19,850
Cost and estimated earnings excess of billings	(1,451,475)	(1,125,610)
Inventory	1,897,320	(3,633,057)
Vendor deposits	(769)	916,494
Prepaid expenses and other current assets	951,720	(448,680)
Accounts payable and accrued expenses	1,842,003	1,340,655
Billings in excess of costs and earnings on uncompleted contracts		(1,388,838)
Deferred revenue	(656,928)	3,941,523
Due to landlord	(372,687)	(279,518)
Operating lease payments	(1,038,889)	(1,170,949)
Net Cash Used in Operating Activities	(8,217,365)	(8,736,350)
Cash Flows From Investing Activities
Cash paid for patent costs	(76,753)	(682)
Purchase of machinery and equipment	(482,888)	(23,017)
Acquisitions, net of cash acquired (Note 2)	(4,115,709)	(10)
Payments on note payable	(166,262)	(152,571)
Net Cash Used in Investing Activities	(4,841,612)	(176,280)
Cash Flows From Financing Activities
Payments on financing leases	(41,379)	(6,591)
Proceeds from officer loan	200,000
Shares repurchased		(149,686)
Dividends to preferred shareholders	(769,481)	(1,449,000)
Proceeds from equity raises, net	11,625,180	2,021,736
Proceeds from note payable, net	441,119	2,462,500
Net Cash Provided by Financing Activities	11,455,439	2,878,959
Net Decrease in Cash and equivalents	(1,603,538)	(6,033,671)
Cash, restricted cash, and cash equivalents at January 1,	2,734,485	8,768,156
Cash, restricted cash, and cash equivalents at December 31,	1,130,947	2,734,485
Supplemental Disclosures of Cash Flow Information:
Interest	816,265	57,534
Supplemental Schedule of Non-Cash Financing and Investing Activities
Conversion of debt into common stock	767,500
Recognition of right of use asset and corresponding liability	563,315	3,527,443
Accrued dividends	849,500
Issuance of Note Payable for payment of prepaid expense	$ 279,347	$ 318,833